Validity and Reliability of the Virtual Reality-Based 9-Hole Peg Test in Stroke Patients
Launched by ANKARA UNIVERSITY · Sep 2, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to assess hand movement and coordination in stroke patients using a virtual reality (VR) version of a common test called the 9-Hole Peg Test. The goal is to see if this VR test is just as reliable and accurate as the traditional physical test for measuring how well patients can use their hands after a stroke. Researchers also want to understand how hand function might differ between a person's dominant hand (the one they use most) and their non-dominant hand in healthy individuals.
To participate in this trial, you need to be diagnosed with a stroke and have some movement in your arm and hand. You should also be able to think clearly and follow simple instructions. If you or your loved one qualifies, you can expect to take part in activities that involve using VR technology to evaluate hand skills. It's important to know that certain conditions, like severe speech difficulties or significant cognitive challenges, may prevent someone from participating. This study is currently looking for volunteers, and all participants will need to give their informed consent before joining.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Receiving a stroke diagnosis according to the WHO definition
- • Upper extremity in stage 3 and above according to Brunnstrom motor staging
- • To be cognitively competent (score of 22 or above on the Mini Mental Test)
- • Balance of sitting
- • The patient or his/her relatives have completed the informed voluntary consent form
- Exclusion Criteria:
- • Presence of severe aphasia
- • Presence of cognitive impairment or psychiatric disorders
- • Detection of a neglect phenomenon
- • Presence of hemianopsia
- • Spasticity in the affected arm, 3 or more according to Modified Ashworth Scale
About Ankara University
Ankara University, a prominent institution in Turkey, is dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on scientific rigor and ethical standards, the university collaborates with various stakeholders to design and implement studies that address critical health challenges. Leveraging a diverse network of experienced researchers and state-of-the-art facilities, Ankara University aims to contribute significantly to the global medical community by generating valuable insights and fostering the development of effective therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Haydar Gok, Professor
Study Director
Ankara University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported